Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 145
- CBD Market
EFSA ‘Stopping The Clock’ On EU CBD Novel Foods Applications, But Doubts Remain Over Decision’s Impact In UK
THE European Food Safety Authority (EFSA) issued a statement last week announcing that its scientists ‘cannot currently establish the safety of cannabidiol (CBD) as a novel food’.
- Adult-Use
European Cannabis Stocks Review: SEED Loses Recent Gains As Stock Drops 30%, DanCann Performs Well Despite Lower Estimates, & More From DeepVerge
THIS week saw news emerge that countries across the globe were making significant moves towards the liberalisation of cannabis regulation, with Spain, Japan and Ukraine all exploring the legalisation of medical cannabis.
- Medical
Spanish Government To Vote On Proposals For Medical Cannabis Legalisation This Month, Marking ‘First Baby Steps’ Towards Full Market
THE SPANISH Government is set to make its final vote on proposals regarding the legalisation of medical cannabis in three weeks time.
- Press releases
New Medical Cannabis Clinic Opens In Guernsey To Support Expanding Patient Community
A NEW clinic giving islanders the opportunity to be prescribed medical cannabis is opening its doors in St Martin this week.
- Medical
Kanabo Posts £4.6m Loss For 2021 But Remains Bullish As It Shifts Focus Towards Dispensing & Prescribing
KANABO has released its first full-year financial results since becoming the second cannabis company in history to launch on the London Stock Exchange (LSE) in February last year.
- Pharmaceutical
European Cannabis Stocks Review: Yooma Wellness Reports More Losses In Q1, Chill Brands Stock Jumps 10% On Open Offer, & More from OCT
Yooma Wellness Just two weeks after publishing its delayed full-year results, in which it reported a $33m loss, Yooma Wellness has released its sales figures for the first quarter of 2022.
- Adult-Use
Jersey Continues To Position Itself As Regional Cannabis Leader As It Issues 5th Cultivation Licence
JERSEY has granted its fifth commercial cannabis licence to early-stage cultivators Green Island Growers, as the Crown Dependency continues to solidify its status as a leading light in the development of the UK medical cannabis industry.
- CBD Market
Cellular Goods Reports First Ever Revenue Figures Of £13k As It Warns Of Slower Than Expected Growth In Second Half
CELLULAR Goods has revealed its first ever sales figures after launching its inaugural product range in December last year.
- Adult-Use
German Government Should Focus On ‘Detail Not Speed’ As It Pressures Ministers To Accelerate Recreational Cannabis Roll Out
FEARS that German health ministers may be dragging their feet on rolling out cannabis legislation were definitively quashed earlier this month, as the Government resorted to unconventional tactics to speed the process along.
- Uncategorized
Die deutsche Regierung sollte sich auf “Details statt Geschwindigkeit” konzentrieren, wenn sie die Minister drängt, die Einführung von Cannabis für den Freizeitgebrauch zu beschleunigen
Befürchtungen, dass die deutschen Gesundheitsminister die Einführung von Cannabisgesetzen hinauszögern könnten, wurden Anfang des Monats endgültig widerlegt, da die Regierung zu unkonventionellen Taktiken griff, um den Prozess zu beschleunigen.
- Markets & Stocks
European Cannabis Stocks Review: SEED Innovations Shares Spike 25%, Futura Medical Signs Commercialisation Deal, & More From Akanda
AS quarterly and full-year results continued to be published across the global cannabis industry, European stocks enjoyed a relatively stable week compared to their North American counterparts, with both Canadian and US indexes experiencing swings in both directions.
- Companies
LYPHE Group Poised For European Expansion As It ‘Steps Into Venture Capital’ With £5m Fundraise Led By Leafy Tunnel
LYPHE Group has announced the successful closure of its latest funding round, securing £5m in capital to fund expansion into ‘multiple markets’ across Europe.











